Canary Cure Press Releases

• Published on November 18, 2024 - 14:00 GMT

  Canary’s First-in-class Dual RNAi Gene Silencing Offers a Novel Approach to Weight Loss and Metabolic Disease Management

  CCT-217 Demonstrates Significant Weight Loss and Preserves Lean Body Mass with Potential for Single or Twice-Yearly Dosing NEW YORK, NY, UNITED STATES, November 18, 2024 /⁨EINPresswire.com⁩/ -- Canary Cure, a biotechnology company focused on developing …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on August 19, 2024 - 16:28 GMT

  Canary Cure Advances Novel siRNA Therapeutic Targeting Obesity into In Vivo Trials

  First-in-Class Gene-Targeted Approach to Promote Fat-Burning, Preserve Lean Body Mass, and Enhance Metabolic Health by Harnessing the Endocannabinoid System VANCOUVER, ONTARIO, CANADA, August 19, 2024 /⁨EINPresswire.com⁩/ -- Canary Cure, a biotechnology …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...